Harvest Group Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11	Closed	-$1.31K	–	198
2022 Q4	$1.31K	Buy	11 +5	+83%	+$597	﹤0.01%	137
2022 Q3	$1K	Buy	+6	New	+$1K	﹤0.01%	148
2022 Q1	–	Sell	-12	Closed	-$1K	–	158
2021 Q4	$1K	Buy	+12	New	+$1K	﹤0.01%	100